ABP

Abpro Holdings, Inc Common Stock
ABP
Market cap $70M

1.35 USD

+0.03

2.27%

At close Jan 22, 4:00 PM EST

After hours

1.35

+0.00

0.00%

1 day

2.27%

5 days

0.75%

1 month

-41.05%

3 months

-63.61%

6 months

-63.61%

Year to date

-14.01%

1 year

-63.61%

5 years

-63.61%

10 years

-63.61%

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.

Healthcare Biological Products, Except Diagnostic Substances

–

Funds holding %

of 6,823 funds

–

Analysts bullish %